24.96
0.10 (0.40%)
| Previous Close | 24.86 |
| Open | 24.51 |
| Volume | 423,398 |
| Avg. Volume (3M) | 493,242 |
| Market Cap | 1,466,959,104 |
| Price / Sales | 3.35 |
| Price / Book | 5.41 |
| 52 Weeks Range | |
| Earnings Date | 28 May 2025 |
| Profit Margin | -13.94% |
| Operating Margin (TTM) | -46.68% |
| Diluted EPS (TTM) | -1.02 |
| Quarterly Revenue Growth (YOY) | 45.70% |
| Total Debt/Equity (MRQ) | 2.60% |
| Current Ratio (MRQ) | 1.78 |
| Operating Cash Flow (TTM) | 32.38 M |
| Levered Free Cash Flow (TTM) | 28.64 M |
| Return on Assets (TTM) | -8.75% |
| Return on Equity (TTM) | -22.67% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Phreesia, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | 1.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 0.0 |
| Average | 0.80 |
|
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 4.65% |
| % Held by Institutions | 100.94% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 35.00 (Canaccord Genuity, 40.22%) | Buy |
| Median | 31.50 (26.20%) | |
| Low | 28.00 (Keybanc, 12.18%) | Buy |
| Average | 31.50 (26.20%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 24.65 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Keybanc | 16 Apr 2025 | 28.00 (12.18%) | Buy | 23.89 |
| DA Davidson | 14 Apr 2025 | 34.00 (36.22%) | Buy | 23.82 |
| Canaccord Genuity | 13 Mar 2025 | 35.00 (40.22%) | Buy | 25.45 |
| Needham | 13 Mar 2025 | 29.00 (16.19%) | Buy | 25.45 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CAHILL EDWARD L | 24.59 | - | 400 | 9,836 |
| GOLDSTEIN LAINIE | 24.59 | - | 400 | 9,836 |
| MUNSON GILLIAN | 24.59 | - | 400 | 9,836 |
| Aggregate Net Quantity | 1,200 | |||
| Aggregate Net Value ($) | 29,508 | |||
| Aggregate Avg. Buy ($) | 24.59 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CAHILL EDWARD L | Director | 30 Apr 2025 | Acquired (+) | 400 | 24.59 | 9,836 |
| GOLDSTEIN LAINIE | Director | 30 Apr 2025 | Acquired (+) | 400 | 24.59 | 9,836 |
| MUNSON GILLIAN | Director | 30 Apr 2025 | Acquired (+) | 400 | 24.59 | 9,836 |
| Date | Type | Details |
|---|---|---|
| 06 May 2025 | Announcement | Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results |
| 29 Apr 2025 | Announcement | Phreesia Sets Release Date for Fiscal First Quarter 2026 Results |
| 13 Mar 2025 | Announcement | Phreesia Named to G2’s List of 2025 Best Healthcare Software Products |
| 12 Mar 2025 | Announcement | Phreesia Announces Fourth Quarter Fiscal 2025 Results |
| 11 Feb 2025 | Announcement | Phreesia’s Sally Thayer Selected as a Top Woman Leader in Software |
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 May 2013 | 07 Feb 2013 | 17 Jun 2013 | 0.5625 Cash |
| 27 Feb 2013 | 06 Feb 2013 | 15 Mar 2013 | 0.5625 Cash |
| 28 Nov 2012 | - | 15 Dec 2012 | 0.5625 Cash |
| 29 Aug 2012 | - | 15 Sep 2012 | 0.5625 Cash |
| 30 May 2012 | - | 15 Jun 2012 | 0.5625 Cash |
| 28 Feb 2012 | - | 15 Mar 2012 | 0.5625 Cash |
| 30 Aug 2011 | - | 15 Sep 2011 | 0.5625 Cash |
| 27 May 2011 | - | 15 Jun 2011 | 0.5625 Cash |
| 25 Feb 2011 | - | 15 Mar 2011 | 0.5625 Cash |
| 29 Nov 2010 | - | 15 Dec 2010 | 0.5625 Cash |
| 30 Aug 2010 | - | 15 Sep 2010 | 0.5625 Cash |
| 27 May 2010 | - | 15 Jun 2010 | 0.5625 Cash |
| 25 Feb 2010 | - | 15 Mar 2010 | 0.5625 Cash |
| 27 Nov 2009 | - | 15 Dec 2009 | 0.5625 Cash |
| 28 Aug 2009 | - | 15 Sep 2009 | 0.5625 Cash |
| 28 May 2009 | - | 15 Jun 2009 | 0.5625 Cash |
| 25 Feb 2009 | - | 16 Mar 2009 | 0.5625 Cash |
| 26 Nov 2008 | - | 15 Dec 2008 | 0.5625 Cash |
| 27 Aug 2008 | - | 15 Sep 2008 | 0.46875 Cash |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |